IL2 and fibrosarcoma: CRP, or its active peptide-fragment, when encapsulated in liposomes, were maximally effective in protecting not only metastases in a murine fibrosarcoma model, but increased survival when liposome-encapsulated CRP (or its peptide) were injected in combination with interleukin-2 (IL-2) (39).